Characterization of the Oligomerization and Aggregation of Human Serum Amyloid A

30Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

Abstract

The fibrillation of Serum Amyloid A (SAA) - a major acute phase protein - is believed to play a role in the disease Amyloid A (AA) Amyloidosis. To better understand the amyloid formation pathway of SAA, we characterized the oligomerization, misfolding, and aggregation of a disease-associated isoform of human SAA - human SAA1.1 (hSAA1.1) - using techniques ranging from circular dichroism spectroscopy to atomic force microscopy, fluorescence spectroscopy, immunoblot studies, solubility measurements, and seeding experiments. We found that hSAA1.1 formed alpha helix-rich, marginally stable oligomers in vitro on refolding and cross-beta-rich aggregates following incubation at 37°C. Strikingly, while hSAA1.1 was not highly amyloidogenic in vitro, the addition of a single N-terminal methionine residue significantly enhanced the fibrillation propensity of hSAA1.1 and modulated its fibrillation pathway. A deeper understanding of the oligomerization and fibrillation pathway of hSAA1.1 may help elucidate its pathological role. © 2013 Patke et al.

Cite

CITATION STYLE

APA

Patke, S., Srinivasan, S., Maheshwari, R., Srivastava, S. K., Aguilera, J. J., Colón, W., & Kane, R. S. (2013). Characterization of the Oligomerization and Aggregation of Human Serum Amyloid A. PLoS ONE, 8(6). https://doi.org/10.1371/journal.pone.0064974

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free